Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anaphylaxis | 21 | 2021 | 757 | 3.690 |
Why?
|
| Food Hypersensitivity | 17 | 2021 | 729 | 2.630 |
Why?
|
| Epinephrine | 12 | 2021 | 792 | 2.150 |
Why?
|
| Insect Bites and Stings | 3 | 2013 | 71 | 0.860 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2010 | 347 | 0.570 |
Why?
|
| Emergency Service, Hospital | 17 | 2021 | 7879 | 0.480 |
Why?
|
| Sunlight | 2 | 2015 | 337 | 0.460 |
Why?
|
| Emergency Treatment | 2 | 2014 | 496 | 0.440 |
Why?
|
| Allergens | 6 | 2021 | 1432 | 0.430 |
Why?
|
| Hospitalization | 10 | 2021 | 10721 | 0.410 |
Why?
|
| Ultraviolet Rays | 3 | 2015 | 1080 | 0.380 |
Why?
|
| Patient Admission | 1 | 2017 | 1367 | 0.340 |
Why?
|
| Vitamin D | 3 | 2015 | 3303 | 0.330 |
Why?
|
| Food | 2 | 2012 | 774 | 0.320 |
Why?
|
| Bronchodilator Agents | 3 | 2014 | 512 | 0.270 |
Why?
|
| Inpatients | 1 | 2017 | 2548 | 0.250 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 4243 | 0.240 |
Why?
|
| Child, Preschool | 16 | 2021 | 42232 | 0.230 |
Why?
|
| Patient Education as Topic | 2 | 2013 | 2319 | 0.220 |
Why?
|
| Injections, Intramuscular | 2 | 2021 | 554 | 0.200 |
Why?
|
| Infant | 12 | 2021 | 36193 | 0.190 |
Why?
|
| Child | 16 | 2020 | 80158 | 0.170 |
Why?
|
| Self Administration | 3 | 2021 | 390 | 0.170 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2021 | 352 | 0.150 |
Why?
|
| Immunoglobulin E | 2 | 2021 | 1502 | 0.150 |
Why?
|
| Nitric Oxide Synthase | 1 | 2000 | 908 | 0.150 |
Why?
|
| Adolescent | 14 | 2021 | 88326 | 0.140 |
Why?
|
| Injections | 1 | 2020 | 831 | 0.140 |
Why?
|
| Rhode Island | 1 | 2017 | 351 | 0.140 |
Why?
|
| International Classification of Diseases | 3 | 2021 | 910 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2000 | 1069 | 0.130 |
Why?
|
| NF-kappa B | 2 | 2003 | 2490 | 0.130 |
Why?
|
| Drug Hypersensitivity | 2 | 2015 | 917 | 0.130 |
Why?
|
| Emergency Medical Services | 4 | 2021 | 1923 | 0.120 |
Why?
|
| Trans-Activators | 2 | 2003 | 2856 | 0.120 |
Why?
|
| Eating | 1 | 2021 | 1539 | 0.120 |
Why?
|
| Seasons | 2 | 2010 | 1520 | 0.120 |
Why?
|
| Length of Stay | 3 | 2017 | 6426 | 0.110 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2015 | 882 | 0.110 |
Why?
|
| Hypersensitivity | 2 | 2021 | 1171 | 0.110 |
Why?
|
| Humans | 36 | 2021 | 761596 | 0.100 |
Why?
|
| Mast Cells | 1 | 2020 | 1392 | 0.100 |
Why?
|
| Eczema | 1 | 2015 | 246 | 0.100 |
Why?
|
| Male | 21 | 2021 | 360846 | 0.100 |
Why?
|
| Allergy and Immunology | 1 | 2013 | 176 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2003 | 4514 | 0.100 |
Why?
|
| Medical Records | 3 | 2015 | 1408 | 0.100 |
Why?
|
| Female | 21 | 2021 | 392705 | 0.090 |
Why?
|
| Bee Venoms | 1 | 2010 | 23 | 0.090 |
Why?
|
| Bees | 1 | 2010 | 46 | 0.090 |
Why?
|
| Obesity | 1 | 2012 | 12947 | 0.090 |
Why?
|
| DNA-Binding Proteins | 3 | 2003 | 9610 | 0.080 |
Why?
|
| Clinical Protocols | 2 | 2012 | 1440 | 0.080 |
Why?
|
| Urticaria | 1 | 2010 | 150 | 0.080 |
Why?
|
| United States | 10 | 2021 | 72340 | 0.080 |
Why?
|
| Angioedema | 1 | 2010 | 184 | 0.080 |
Why?
|
| Skin Tests | 1 | 2010 | 637 | 0.080 |
Why?
|
| Infant, Newborn | 4 | 2021 | 26202 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2003 | 12130 | 0.070 |
Why?
|
| Urban Population | 1 | 2015 | 2036 | 0.070 |
Why?
|
| Consensus | 3 | 2021 | 3124 | 0.070 |
Why?
|
| Delphi Technique | 2 | 2021 | 846 | 0.070 |
Why?
|
| Age Factors | 4 | 2017 | 18399 | 0.070 |
Why?
|
| Parturition | 1 | 2010 | 448 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2010 | 1186 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2010 | 2280 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2014 | 9647 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2927 | 0.060 |
Why?
|
| Age Distribution | 1 | 2010 | 2879 | 0.060 |
Why?
|
| Adult | 12 | 2020 | 221210 | 0.060 |
Why?
|
| Retrospective Studies | 6 | 2021 | 80647 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2014 | 1937 | 0.060 |
Why?
|
| Drug Prescriptions | 1 | 2013 | 1670 | 0.060 |
Why?
|
| Treatment Outcome | 5 | 2021 | 64685 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2003 | 315 | 0.050 |
Why?
|
| Diet | 1 | 2021 | 8075 | 0.050 |
Why?
|
| Comorbidity | 2 | 2015 | 10508 | 0.050 |
Why?
|
| Risk | 1 | 2014 | 9610 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4853 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 14608 | 0.050 |
Why?
|
| Risk Factors | 6 | 2015 | 74213 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 7828 | 0.050 |
Why?
|
| Egg Hypersensitivity | 1 | 2021 | 47 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2014 | 3242 | 0.050 |
Why?
|
| Prevalence | 2 | 2015 | 15733 | 0.050 |
Why?
|
| Synaptotagmin I | 1 | 2000 | 33 | 0.050 |
Why?
|
| Synaptotagmins | 1 | 2000 | 53 | 0.040 |
Why?
|
| Eggs | 1 | 2021 | 182 | 0.040 |
Why?
|
| Synovial Membrane | 1 | 2003 | 532 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2003 | 1248 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2000 | 517 | 0.040 |
Why?
|
| Middle Aged | 9 | 2015 | 220921 | 0.040 |
Why?
|
| Peanut Hypersensitivity | 1 | 2021 | 219 | 0.040 |
Why?
|
| Critical Illness | 1 | 2010 | 2723 | 0.040 |
Why?
|
| Young Adult | 6 | 2015 | 59260 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 7406 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 2013 | 7391 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2010 | 8633 | 0.030 |
Why?
|
| Asthma | 1 | 2015 | 6234 | 0.030 |
Why?
|
| Time Factors | 2 | 2014 | 39969 | 0.030 |
Why?
|
| Aged | 6 | 2013 | 169310 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2020 | 931 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 1756 | 0.030 |
Why?
|
| Adrenergic Agonists | 1 | 2013 | 58 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3792 | 0.030 |
Why?
|
| Quality of Life | 1 | 2015 | 13367 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1626 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2020 | 1530 | 0.030 |
Why?
|
| Research | 1 | 2021 | 1982 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2001 | 5790 | 0.030 |
Why?
|
| Incidence | 1 | 2010 | 21355 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2000 | 1161 | 0.020 |
Why?
|
| Binding Sites | 1 | 2000 | 6056 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2000 | 1886 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 4352 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2010 | 58984 | 0.020 |
Why?
|
| Shellfish | 1 | 2010 | 37 | 0.020 |
Why?
|
| Animals | 3 | 2013 | 168475 | 0.020 |
Why?
|
| Blotting, Northern | 2 | 2003 | 1545 | 0.020 |
Why?
|
| Acute Disease | 1 | 2021 | 7237 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15843 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2000 | 3701 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2001 | 3612 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2010 | 23996 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 39106 | 0.020 |
Why?
|
| Recurrence | 1 | 2020 | 8466 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2000 | 4415 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2003 | 3763 | 0.020 |
Why?
|
| Logistic Models | 2 | 2013 | 13255 | 0.020 |
Why?
|
| Boston | 2 | 2010 | 9327 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 3415 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2010 | 41495 | 0.020 |
Why?
|
| Cytokines | 1 | 2000 | 7396 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2000 | 18966 | 0.010 |
Why?
|
| Disease Progression | 1 | 2020 | 13510 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2013 | 2220 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 2003 | 416 | 0.010 |
Why?
|
| Receptors, TIE | 1 | 2001 | 10 | 0.010 |
Why?
|
| Receptor, TIE-1 | 1 | 2001 | 13 | 0.010 |
Why?
|
| Allantois | 1 | 2001 | 33 | 0.010 |
Why?
|
| Chorion | 1 | 2001 | 114 | 0.010 |
Why?
|
| Inflammation | 1 | 2000 | 10774 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2013 | 3600 | 0.010 |
Why?
|
| Receptor, TIE-2 | 1 | 2001 | 176 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2013 | 3443 | 0.010 |
Why?
|
| Vitamin D Deficiency | 1 | 2010 | 1388 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12059 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2003 | 1704 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2001 | 982 | 0.010 |
Why?
|
| Chickens | 1 | 2001 | 859 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2014 | 7968 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 2820 | 0.010 |
Why?
|
| Cell Line | 2 | 2003 | 15601 | 0.010 |
Why?
|
| Chondrocytes | 1 | 2003 | 795 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2003 | 1143 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2001 | 790 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2001 | 1900 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 2748 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2001 | 2180 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2001 | 1968 | 0.010 |
Why?
|
| Mutation | 1 | 2000 | 30053 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4576 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2003 | 2206 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 4174 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 2003 | 1063 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2001 | 1113 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 4142 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2001 | 2822 | 0.010 |
Why?
|
| Macrophages | 1 | 2003 | 5767 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 17635 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2003 | 12794 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 11076 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 5799 | 0.000 |
Why?
|
| Mice | 1 | 2001 | 81539 | 0.000 |
Why?
|
Concepts
(174)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_